Fair 31°
News
COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says
Covid-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says New studies have found that Americans receiving the first dose of the two-shot Moderna and Pfizer COVID-19 vaccine may be protected against the spread of the vaccine. According to a Bloomberg report, out of more than 1,000 staff members tested at Cedars-Sinai Medical Center in Los Angeles, many responded to the first dose so robustly that their results were similar to co-workers who received both doses. Research leader Susan Cheng, who co-authored a study published in the Nature Medicine journal, said that those who have already contracted the virus, immune responses after one vaccine have …

SHARE

by Zak Failla
News
COVID-19: Moderna Seeks Full FDA Approval For Vaccine COVID-19: Moderna Seeks Full FDA Approval For Vaccine
Covid-19: Moderna Seeks Full FDA Approval For Vaccine With six months having passed since Moderna began clinical trials for its COVID-19 vaccine, the pharmaceutical company is seeking full approval from the Food and Drug Administration. Moderna, which currently has emergency use authorization from the FDA to distribute its vaccine, reported in its latest trial data that it has proven 90 percent effective in preventing the symptoms of COVID-19, and 95 percent effective in the most severe cases of the virus. Currently, no COVID-19 vaccine is fully approved by the FDA, but three - Moderna, Pfizer, and the currently questionable Johnson & John…

SHARE

by Zak Failla
News
COVID-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose COVID-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose
Covid-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose Pfizer CEO Albert Bourla is cautioning that patients will likely need a third dose of the company’s COVID-19 vaccine within the next year to maintain the shot’s efficacy. During a recently aired interview, Bourla said that patients will “likely” need an additional dose of the vaccine within 12 months of becoming fully vaccinated with the two required doses. Bourla said that they are continuing to monitor the situation, and as more COVID-19 variants arise, the company may be forced to shift gears. “We need to see what would be the sequence, and for how often we need to do that, that remains…

SHARE

by Zak Failla
News
CDC, FDA Call For Pause On Johnson & Johnson Vaccine CDC, FDA Call For Pause On Johnson & Johnson Vaccine
CDC, FDA Call For Pause On Johnson & Johnson Vaccine The US Centers for Disease Control and Prevention and the US Food and Drug Administration are calling for a pause on the use of Johnson & Johnson's COVID-19 vaccine due to six cases of "rare and severe" blood clot cases reported. All six cases occurred among women between 18 and 48, and symptoms occurred 6 to 13 days after vaccination, FDA officials said in a joint statement. More than 6.8 million doses of the one-dose vaccine had been administered in the U.S. All Pennsylvania teachers and administrators were given the J&J vaccine. Out of the 200,000 offered the vaccine a…

SHARE

by Cecilia Levine
News
COVID-19: Closure Of J&J Vaccine Clinic, Supply Glitch Both Causing Concerns COVID-19: Closure Of J&J Vaccine Clinic, Supply Glitch Both Causing Concerns
Covid-19: Closure Of J&J Vaccine Clinic, Supply Glitch Both Causing Concerns The mass rollout of the Johnson & Johnson COVID-19 vaccine has hit enough roadblock as a vaccination site was forced to close due to people suffering adverse reactions to the shot. A vaccine clinic administering the one-shot Johnson & Johnson vaccine in Colorado was forced to shut down, and the federal government announced it will be shipping fewer of the company’s doses around the country due to production issues. The company did not say how many people had reactions but said it amounted to 0.8 percent of those who received a vaccine dose Wednesday, April 7. Health officials in Co…

SHARE

by Zak Failla
News
COVID-19: Millions Of J&J Doses Thrown Away After Factory Mixup COVID-19: Millions Of J&J Doses Thrown Away After Factory Mixup
Covid-19: Millions Of J&J Doses Thrown Away After Factory Mixup Millions of doses of the Johnson & Johnson COVID-19 vaccine had to be destroyed after there was a dosage mix-up at a production lab, prompting a delay in shipments to states. According to reports, employees at Emergent BioSolutions, a production facility in Baltimore that produces the vaccine, mixed up two ingredients, ruining approximately 15 million doses of the vaccine. Emergent is one of several companies that Johnson & Johnson enlisted to speed up manufacturing of its recently approved vaccine, the company said. The Baltimore factory where the tainted vaccine ingredient was fou…

SHARE

by Zak Failla
Lifestyle
COVID-19: Here's Percentage Of Americans Who Think Pandemic Is Improving, New Poll Shows COVID-19: Here's Percentage Of Americans Who Think Pandemic Is Improving, New Poll Shows
Covid-19: Here's Percentage Of Americans Who Think Pandemic Is Improving, New Poll Shows Americans are feeling more optimistic about the nation’s ability to bring the pandemic crisis to an end, according to a new survey. On Friday, March 5, about one year after the pandemic began, Gallup released the outcome of its latest national COVID-19 opinion poll. The survey looked into what American adults are thinking about COVID-19 trends, access to vaccines and tests, and how the pandemic is affecting their lives. Here are some of the survey’s highlights: COVID-19 Gallup found that 60 percent of Americans said the COVID-19 situation in the U.S. is improving. This is the most upbeat…

SHARE

by Kristin Palpini
Lifestyle
COVID-19: Taking Aspirin Regularly May Help Prevent Infection, New Study Says COVID-19: Taking Aspirin Regularly May Help Prevent Infection, New Study Says
Covid-19: Taking Aspirin Regularly May Help Prevent Infection, New Study Says Waiting to get a vaccine? In the meantime, there may be something already in your cupboard that could prevent you from becoming infected with COVID-19, according to a new study. Those who took a low dose of aspirin on a regular basis were 29 percent less likely to become infected, according to research conducted in Israel. Data from about 10,000 people who were tested for COVID between Feb. 1, 2020, and June 30, 2020 was evaluated and published in the Federation of European Biochemical Societies Journal, which also determined that "aspirin use is associated with better outco…

SHARE

by Joe Lombardi
News
COVID-19: Did You Already Have Virus, And Not Know It? Here Are The Signs COVID-19: Did You Already Have Virus, And Not Know It? Here Are The Signs
Covid-19: Did You Already Have Virus, And Not Know It? Here Are The Signs Not everyone who has caught COVID-19 knows it. But there are ways to tell if you got the novel virus sometime since the pandemic touched down in the U.S. during winter 2020. In many people, signs of “Long COVID-19" persist, according to a new study, “Long COVID: a cross-sectional study of persisting symptoms” led by Dr. Swapna Mandal, a respiratory physician, and a growing host of research. There’s only one true way to know if you had COVID-19 - get an antibody blood test to check for signs of COVID-19. However, there are a number of more informal ways to tell if you previously caught t…

SHARE

by Kristin Palpini
News
COVID-19: New Study Reveals Danger To Younger Americans, Who Are Dying At Historic Rate COVID-19: New Study Reveals Danger To Younger Americans, Who Are Dying At Historic Rate
Covid-19: New Study Reveals Danger To Younger Americans, Who Are Dying At Historic Rate Contrary to popular belief, COVID-19 is taking its toll on younger Americans, who are dying at a historic rate, according to a new study. Research published this week in the Journal of American Medical Association found that Americans between the ages of 25 and 44 have died at a rate that has never been seen in history. During the study, a total of 76,088 deaths were reported in adults between those ages, which was 11,899 more than the expected 64,189 fatalities during that stretch. Of those deaths, 38 percent were contributed to COVID-19. “Although the remaining excess deaths are unexpla…

SHARE

by Zak Failla
Lifestyle
COVID-19: New Report Projects How Long It Will Take NYC Tourism To Return To Pre-Pandemic Level COVID-19: New Report Projects How Long It Will Take NYC Tourism To Return To Pre-Pandemic Level
Covid-19: New Report Projects How Long It Will Take NYC Tourism To Return To Pre-Pandemic Level It could be years until tourism fully recovers from the effects of the COVID-19 pandemic, according to a new report. In a report from NYC & Company released on Monday, Nov. 16, due to a lack of international tourists expected back in the Big Apple for some time due to the pandemic, as well as domestic travel restrictions, the city may not return to its 2019 pre-pandemic level before 2025. According to NYC & Company, which commissioned the study, a return to normalcy and tourism largely hinges on when or if a vaccine is distributed, and how effective it is. NYC & Company’s repor…

SHARE

by Zak Failla
Lifestyle
COVID-19: Will You Get A Coronavirus Vaccine? Here's Percentage Who Said Yes In New Survey COVID-19: Will You Get A Coronavirus Vaccine? Here's Percentage Who Said Yes In New Survey
Covid-19: Will You Get A Coronavirus Vaccine? Here's Percentage Who Said Yes In New Survey Based on a survey of 20,000 worldwide conducted by the World Economic Forum, about three-quarters of people say they would get a COVID-19 vaccine if one was available.  Among that 74 percent, 37 percent "strongly agree" that they will get a vaccine, while 37 percent somewhat agree.  In the United States, 67 percent of those polled would get an inoculation against COVID-19 if one were available. The most common concern amongst those who had trepidations about a vaccine were possible side effects.  Except for the U.S., all of the countries most willing to take a vaccine are t…

SHARE

by Christina Coulter